This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.
Strategies to Effectively Manage ID and IDA Throughout the Life Span
Strategies to Effectively Manage ID and IDA Throughout the Life Span
Welcome to CME on ReachMD. This episode is part of our MinuteCME curriculum.
Prior to beginning the activity, please be sure to review the faculty and commercial support disclosure statements as well as the learning objectives.
Hello, this is CME on ReachMD. I’m Dr. Malcolm Munro from UCLA, and I’m here with Dr. Wendy Wright from New Hampshire to talk about clinical points in managing individuals with iron deficiency. Wendy, what can you tell us?
So let me just start by introducing myself, and welcome and thank you, Dr. Munro. I’m Wendy Wright. I am an adult and family nurse practitioner and the owner of a nurse practitioner-owned and -operated primary care clinic located in New Hampshire, where I have 11 nurse practitioners and about 6,500 primary care patients, so it’s truly my pleasure to be here today.
Let’s jump right in, because I know we have limited time, and I know that you asked me to provide a little bit in the way of insights with regard to iron deficiency. The first thing, as a primary care provider, is that if you’re not seeing iron deficiency or iron deficiency anemias, you’re not looking for them. So it’s really important that we’re assessing both men and women who are at risk for both iron deficiency and iron deficiency anemia. You know, iron deficiency affects diseases that people already have. For instance, it can make their fatigue worse, it can certainly worsen depression in patients who are already affected. It can also increase the risk of cardiovascular events and disease and make conditions like restless legs syndrome worse. So appreciating how important it is in its own entity but also its impact on other diseases is really imperative for our primary care colleagues.
Second, we often will recommend over-the-counter medications for our patients with iron deficiency. And we’ll send them out to the pharmacy to pick up ferrous sulfate or ferrous gluconate. But when we do that, studies have really shown that when we give patients a recommendation to purchase over-the-counter meds, it doesn’t feel as important to them as if we actually write a prescription. So one of the suggestions I have is that you take out your EHR system and that you write them a prescription for the oral iron because that really will elevate the importance.
And last, with iron deficiency, we really would expect to see changes in their numbers fairly quickly. I think it’s important that you follow up to ensure that, A, they’re taking their meds, B, that they are tolerating them okay, and 3, to make sure that you’re monitoring those lab indices to make sure that they’re truly responding to the iron that we’re giving them. I think these are all just some tips on ways that we can improve patient uptake with their medicines and also patient adherence.
So, Wendy, when do you think – just give a little guidance to the appropriate times for reassessing them, perhaps, with ferritin, hemoglobin measurements, as well as how well they’re tolerating. When do you do that?
Sure. I know that we begin to see changes within just a couple of weeks. But once you’ve corrected – if it is an anemia – once you’ve corrected the anemia, it can take 3 to 6 months to fill that savings account up, or what we call the ferritin – but the savings account. So it’s really important that we educate our patients that their treatment doesn’t stop once an anemia is corrected, but that they really continue on with their iron in order to make sure that we’re giving them those iron stores.
That’s great. Well, this has been a wonderful introduction to how to translate what we’ve been learning into clinical practice. So that’s all the time we have now. Thanks for tuning in.
You have been listening to CME on ReachMD. This activity is provided by Omnia Education and is part of our MinuteCME curriculum.
To receive your free CME credit, or to download this activity, go to ReachMD.com/Omnia . Thank you for listening.
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Malcolm G. Munro MD, FRCS(c), FACOG
Clinical Professor, Department of Obstetrics & Gynecology
David Geffen School of Medicine at UCLA
Chair, Women’s Health Research Collaborative
Los Angeles, CA
Research: AbbVie, Pharmacosmos
Ownership Interest: Channel Medical, Okon, Gynesonics, U-Vision 360
Patent Holder: Simulators – Assigned to AAGL
Consulting Fees: AbbVie, American Regent
Michael Auerbach, MD
Clinical Professor of Medicine
Georgetown University School of Medicine
Research: Covis Pharma
Arjeme Denise Cavens, MD
Instructor of Obstetrics and Gynecology
Northwestern University Feinberg School of Medicine
No relevant relationships reported.
Michael K. Georgieff, MD
Martin Lenz Harrison Land Grant Chair in Pediatrics
Professor of Pediatrics, Obstetrics and Gynecology, and Developmental Psychology
University of Minnesota Medical School
No relevant relationships reported.
Lee P. Shulman, MD, FACOG, FACMG
The Anna Ross Lapham Professor and Chief
Division of Clinical Genetics
Feinberg School of Medicine of Northwestern University
Consulting Fees: Agile, Aspira, Bayer, Biogix, Celula China, Daiichi Sankyo, Mayne, Organon, Shield
Other: Astellas (DSMB Chair)
Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
Owner and Family Nurse Practitioner
Wright & Associates Family Healthcare
Consulting Fees: AbbVie, Biohaven, GSK, Idorsia, Merck, Moderna, Pfizer, Sanofi, Seqirus, Shield Therapeutics
- Jennifer Brutsche, RN, BSN, AHA BLS Instructor, has nothing to disclose.
- Cindy Davidson has nothing to disclose.
- Libby Lurwick has nothing to disclose.
- Kate Nagele has nothing to disclose.
- Robert Schneider, MSW, has nothing to disclose.
After participating in this educational activity, participants should be better able to:
- Describe the basics of iron physiology, including its critical role in cellular processes, and impact on growth and development throughout the life span.
- Identify appropriate screening and diagnosis methods throughout the life span.
- Describe the potential impact of iron deficiency (ID)/ ID anemia (IDA) and its treatment, throughout the life span.
- Identify the benefits and disadvantages of using oral iron therapies in the management of iron deficiency (ID) and ID anemia (IDA).
This activity is designed to meet the educational needs of obstetrician-gynecologists, other women’s health HCPs, and primary care physicians.
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1.0 nursing contact hour. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until March 31, 2024. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.
This activity is supported by an independent educational grant from Shield Therapeutics.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction of this material is not permitted without written permission from the copyright owner.
Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.